Distribution of large varieties of Chinese medicine! Dry goods collection!

Pharmaceutical Network July 2nd,large varieties are the soul of Chinese medicine enterprises!Large varieties for Chinese medicine enterprises to contribute scale, profit and brand, to help enterprises successfully listed and support the market value, large varieties have become the core competitiveness of Chinese medicine enterprises, so through the analysis of large varieties can be a glimpse of the Chinese medicine industryThis article is analyzed according to sales volume and technological competitivenessRankingsales by sales is the most intuitive and simple indicator to measure the size of the variety, anddrugmainly sold to patients through two channels, medical institutions and retail pharmacies, Chinese medicine injections are the main force of the large varieties of Chinese medicineTherefore, the following from the dosage form, marketing channels and other aspects of the analysisTop 20varieties of medical institutions2019 national public medical institutions (urban publichospitals
, county-level public hospitals, urban community centers (stations) and township hospitals) the largest sales of traditional Chinese medicine is injection thrombosis, up to 6.28 billion yuan, in sales TOP20, the fastest growth rate is Yangzijiang's blue jaundice? service, growth rate of up to 33%In recent years, with the restriction sediton of auxiliary drugs and the strengthening of rational drug use, Chinese medicine injections have been greatly affected, sales of TOP20 varieties, the number of Chinese medicine injections gradually decreased, the number of oral Chinese medicine gradually increased, in 2019 TOP20 has 8 oral Chinese medicine finalists (Figure 3 red column), while before TOP20 only a few oral varieties, the vast majority of the other are Chinese medicine injectionsretailpharmacies Top 20 varieties retail pharmacies are one of the main battlegrounds of traditional Chinese medicine, in 2019, the largest sales of Chinese medicine in China's urban retail pharmacies is Dong'a gum, up to 3.9 billion yuan, followed by 39 cold particles 2.2 billion yuan, Angong cattle yellow pills (Beijing Tongrentang) 1.8 billion yuan; Tongrentang's Angong ox yellow pills not only sales, but also the fastest growth rate, up to 35%, followed by Yangzijiang's blue-and-white oral solution (34%), Yangzijiang blue-yu oral liquid growth rate won medical institutions, urban pharmacies crown, runner-up, can be seen Yangzijiang's sales capacity according to the competitiveness of science and technology ranking
from the local version of the auxiliary drug catalog, to the national version of the key monitoring directory, especially at present the National Health Insurance Bureau requires the local deadline to focus on monitoring varieties out of health insurance, all reflects the official clean-up of non-therapeutic drugs resolute attitude Although the national version of the key monitoring catalog does not contain Chinese medicine, but the local version of the focus of monitoring has mostly included Chinese medicine, especially before the auxiliary drug source of Chinese medicine injections, so in addition to sales, the clinical value of the variety and scientific and technological content can better reflect the long-term competitiveness of large varieties of Chinese medicine 　　The most authoritative in this regard is the Chinese Medical Society group standard project of the evaluation of the Chinese medicine large varieties of science and technology competitiveness project group evaluation method, it is from the "clinical, science and technology, market" 3 dimensions, according to science and technology investment 20%, science and technology output 50%, science and technology reward 20% and other individual 10% of the 4 The initial proportion of first-level indicators to establish an evaluation model, all of the country's large varieties of Chinese medicine science and technology factors (i.e large varieties of Chinese medicine technology competitiveness) ranking, in 2019 a total of 579 products shortlisted for the Chinese medicine large varieties of scientific and technological competitiveness ranking, involving 380 enterprises , 530 varieties 　　Guangdong Large Varieties of Traditional Chinese Medicine the provinces that are shortlisted for the 2019 Chinese medicine large varieties of science and technology competitiveness list are Guangdong, a total of 47 varieties were shortlisted, of which Guangzhou Baiyunshan enterprises accounted for 16, respectively, thirst-cancelling pills, children's seven-star tea particles, Guangdong herbal tea particles, Huayu re-creation pills and other well-known brands; Each of the 39 varieties shortlisted, Guizhou shortlisted varieties of the largest number of enterprises are Guizhou Yiyi, there are 7 (gram cough capsules, golden bone lotus capsules, compound plaque capsules, etc.), Jilin shortlisted enterprises are Tonghua Golden Horse, there are 3 (strong bone stretch capsules, healing codums, rheumatic pain capsules) shortlisted The top eight provinces (Guangdong, Guizhou, Jilin, Sichuan, Shandong, Jiangsu, Beijing and Hebei) accounted for half of the country, with 285 species shortlisted the top four treatment areas of large varieties of more than half by the treatment field, the largest number of finalists are the treatment of cardiovascular disease drugs, a total of 117 finalists, accounting for 1/5 of the total number of the country, such as the heart-to-heart capsule (step length), musk heart pills (Shanghai and yellow), etc.; exploring the distribution and development law of large varieties of Chinese medicine can provide an important reference for the research and development projects of Chinese medicine enterprises, the formulation of marketing strategies and the adjustment of enterprise strategy and even the valuation of investment mergers and acquisitions 　　With the continuous deepening of the implementation of the Chinese Medicine Law, in October 2019, General Secretary Xi Jinping "follows the law of the development of Chinese medicine, inherits the essence, keeps the right innovation, accelerates the modernization and industrialization of Chinese medicine" under the guidance of the important instructions, as well as the new crown epidemic period of everyone's awareness of the clinical value of Chinese medicine, the Chinese medicine industry is ushering in a rapid development stage, will also be the birth of more large varieties of Chinese medicine Of course, with the progress of the times, the Chinese medicine varieties have also been given a richer connotation, in addition to marketing and other capabilities, clinical value, scientific value as the core of scientific and technological innovation driven, will become the key driving force for the high-quality development of the Chinese medicine industry 　　This article is originally published by Dr Zhang Nature, reproduced please indicate the author, violators will be investigated! Author's email 5620562@qq.com